Home › Asset managers › Compare 2025-2026 › JPMorgan vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,248 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
JPMorgan 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 30,437 | 24,523 | 1,668 | 4,246 | 93.6% | 88.3% |
| Board proposals | 24,375 | 19,281 | 1,523 | 3,571 | 92.7% | 87.6% |
| E&S shareholder proposals | 144 | 7 | 0 | 137 | 100.0% | 43.7% |
| Other items | 5,918 | 5,235 | 145 | 538 | 97.3% | 92.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
3,571 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | JPMorgan | Brighthouse |
|---|---|---|---|---|---|---|
| COUSINS PROPERTIES INCORPORATED | April 28, 2026 | Ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| COVENANT LOGISTICS GROUP, INC. | May 13, 2026 | Advisory and non-binding vote to approve the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | FOR 1 fund |
Split 1 FOR, 1 ABSTAIN |
| CRANE COMPANY | April 27, 2026 | Ratification of the selection of Deloitte & Touche LLP as the Company's independent auditors for 2026. Audit-related |
Board | For | FOR 4 funds |
Split 4 FOR, 3 ABSTAIN |
| CRANE COMPANY | April 27, 2026 | Say on Pay - An advisory vote to approve the compensation paid to certain executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 4 FOR, 3 ABSTAIN |
| CRANE NXT, CO. | May 21, 2026 | Ratification of the selection of Deloitte & Touche LLP as the Company's independent auditors for 2026. Audit-related |
Board | For | FOR 3 funds |
Split 3 FOR, 2 ABSTAIN |
| CRANE NXT, CO. | May 21, 2026 | Say on Pay - An advisory vote to approve the compensation paid by the Company to its named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 3 FOR, 2 ABSTAIN |
| CREDIT ACCEPTANCE CORPORATION | June 10, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 1 fund |
Split 2 AGAINST, 1 ABSTAIN |
| CRH PLC | May 7, 2026 | Authority to Allot Shares Capital Structure |
Board | For | FOR 4 funds |
Split 6 FOR, 1 AGAINST |
| CRH PLC | May 7, 2026 | Authority to Re-issue Treasury Shares Capital Structure |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| CRH PLC | May 7, 2026 | Disapplication of Pre-emption Rights Capital Structure |
Board | For | FOR 4 funds |
Split 5 FOR, 2 AGAINST |
| CRH PLC | May 7, 2026 | Preference Shares Cancellation: Approval of Amendments to Articles Capital Structure |
Board | For | FOR 4 funds |
Split 6 FOR, 1 ABSTAIN |
| CRINETICS PHARMACEUTICALS, INC. | June 18, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; Say-on-Pay |
Board | For | FOR 7 funds |
Split 3 FOR, 1 ABSTAIN |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan. Compensation |
Board | For | FOR 4 funds |
Split 2 FOR, 2 AGAINST |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum equity for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. Compensation |
Board | For | FOR 4 funds |
Split 2 FOR, 2 AGAINST |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. Compensation |
Board | For | FOR 4 funds |
Split 2 FOR, 2 AGAINST |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum non- performance-related compensation for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. Compensation |
Board | For | FOR 4 funds |
Split 2 FOR, 2 AGAINST |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026. Compensation |
Board | For | FOR 4 funds |
Split 2 FOR, 2 AGAINST |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Non-binding advisory vote on the 2025 Compensation Report. Say-on-Pay |
Board | For | FOR 4 funds |
Split 2 FOR, 2 AGAINST |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. Say-on-Pay |
Board | For | FOR 5 funds |
Split 2 FOR, 2 AGAINST |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Briggs W. Morrison, M.D. Director Elections |
Board | For | AGAINST 4 funds |
Split 3 FOR, 1 AGAINST |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of H. Edward Fleming, Jr., M.D. Director Elections |
Board | For | AGAINST 4 funds |
Split 3 FOR, 1 AGAINST |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of John T. Greene Director Elections |
Board | For | AGAINST 4 funds |
Split 3 FOR, 1 AGAINST |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Simeon J. George, M.D. Director Elections |
Board | For | AGAINST 4 funds |
Split 3 FOR, 1 AGAINST |
| CROCS, INC. | June 9, 2026 | An advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
Split 4 FOR, 1 ABSTAIN |
| CROCS, INC. | June 9, 2026 | Approval of the Crocs, Inc. 2026 Equity Incentive Plan. Compensation |
Board | For | FOR 5 funds |
Split 2 FOR, 3 AGAINST |
| CROCS, INC. | June 9, 2026 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 5 funds |
Split 4 FOR, 1 ABSTAIN |
| CROWDSTRIKE HOLDINGS, INC. | June 17, 2026 | To ratify the selection of PricewaterhouseCoopers LLP as CrowdStrike's independent registered public accounting firm for its fiscal year ending January 31, 2027. Audit-related |
Board | For | FOR 13 funds |
Split 9 FOR, 3 ABSTAIN |
| CROWN CASTLE INC. | May 20, 2026 | The non-binding, advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 10 funds |
Split 3 FOR, 1 AGAINST, 2 ABSTAIN |
| CROWN CASTLE INC. | May 20, 2026 | The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accountants for fiscal year 2026. Audit-related |
Board | For | FOR 7 funds |
Split 4 FOR, 2 ABSTAIN |
| CROWN HOLDINGS, INC. | April 30, 2026 | Approval by advisory vote of the resolution on executive compensation as described in the Proxy Statement. Say-on-Pay |
Board | For | FOR 8 funds |
Split 3 FOR, 2 ABSTAIN |
| CROWN HOLDINGS, INC. | April 30, 2026 | Ratification of the appointment of independent auditors for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 2 ABSTAIN |
| CSX CORPORATION | May 12, 2026 | Advisory (non-binding) resolution to approve compensation for the Company's named executive officers. Say-on-Pay |
Board | For | FOR 16 funds |
Split 8 FOR, 1 AGAINST, 3 ABSTAIN |
| CSX CORPORATION | May 12, 2026 | The ratification of the appointment of Ernst & Young LLP as the Independent Registered Public Accounting Firm for 2026. Audit-related |
Board | For | FOR 12 funds |
Split 8 FOR, 1 AGAINST, 3 ABSTAIN |
| CTBC Financial Holding Co., Ltd. | June 12, 2026 | Approve Issuance of Restricted Stocks Compensation |
Board | For | FOR 5 funds |
Split 1 FOR, 1 AGAINST |
| CTS CORPORATION | May 14, 2026 | Approval, on an advisory basis, of the compensation of CTS' named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| CTS CORPORATION | May 14, 2026 | Ratification of the appointment of Grant Thornton LLP as CTS' independent auditor for 2026. Audit-related |
Board | For | FOR 3 funds |
Split 3 FOR, 1 ABSTAIN |
| CUBESMART | May 19, 2026 | To cast an advisory vote to approve our executive compensation. Say-on-Pay |
Board | For | FOR 9 funds |
Split 3 FOR, 5 ABSTAIN |
| CUBESMART | May 19, 2026 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 3 FOR, 5 ABSTAIN |
| CULLEN/FROST BANKERS, INC. | April 29, 2026 | Election of Director to serve for a one-year term that will expire at the 2027 Annual Meeting of Shareholders: Hope Andrade Director Elections |
Board | For | FOR 4 funds |
Split 1 FOR, 3 ABSTAIN |
| CULLEN/FROST BANKERS, INC. | April 29, 2026 | To provide nonbinding approval of executive compensation. Compensation |
Board | For | FOR 6 funds |
Split 1 FOR, 3 ABSTAIN |
| CULLEN/FROST BANKERS, INC. | April 29, 2026 | To ratify the selection of Ernst & Young LLP to act as independent auditors of Cullen/Frost Bankers, Inc. for the fiscal year that began January 1, 2026. Audit-related |
Board | For | Split 4 FOR, 1 AGAINST |
Split 1 FOR, 3 ABSTAIN |
| CUMMINS INC. | May 12, 2026 | Advisory vote to approve the compensation of our named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 12 funds |
Split 7 FOR, 1 AGAINST, 2 ABSTAIN |
| CURBLINE PROPERTIES CORP. | May 7, 2026 | Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | FOR 7 funds |
Split 4 FOR, 1 ABSTAIN |
| CURBLINE PROPERTIES CORP. | May 7, 2026 | Ratification of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 4 FOR, 1 ABSTAIN |
| CURTISS-WRIGHT CORPORATION | May 7, 2026 | An advisory (non-binding) vote to approve the compensation of the Company's named executive officers Say-on-Pay |
Board | For | FOR 5 funds |
Split 5 FOR, 1 AGAINST, 3 ABSTAIN |
| CURTISS-WRIGHT CORPORATION | May 7, 2026 | To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026 Audit-related |
Board | For | FOR 3 funds |
Split 5 FOR, 1 AGAINST, 3 ABSTAIN |
| CUSHMAN & WAKEFIELD LTD. | May 14, 2026 | Appointment of KPMG LLP as independent auditor for the fiscal year ending December 31, 2026, and authorization of the Audit Committee to set the independent auditor's remuneration. Audit-related |
Board | For | FOR 9 funds |
Split 4 FOR, 1 ABSTAIN |
| CUSHMAN & WAKEFIELD LTD. | May 14, 2026 | Non-binding, advisory vote on the compensation of our Named Executive Officers as disclosed in the Proxy Statement ("Say-on-Pay"). Say-on-Pay |
Board | For | FOR 10 funds |
Split 4 FOR, 1 ABSTAIN |
| CUSTOMERS BANCORP, INC. | May 26, 2026 | Election of Director: Steven J. Zuckerman Director Elections |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 1 fund |
| CUSTOMERS BANCORP, INC. | May 26, 2026 | To approve a non-binding advisory resolution on named executive officer compensation. Say-on-Pay |
Board | For | FOR 5 funds |
Split 1 FOR, 3 AGAINST, 1 ABSTAIN |
| CUSTOMERS BANCORP, INC. | May 26, 2026 | To approve an amendment to the Company's 2019 Stock Incentive Plan. Compensation |
Board | For | Split 1 FOR, 3 AGAINST |
Split 4 AGAINST, 1 ABSTAIN |
| CUSTOMERS BANCORP, INC. | May 26, 2026 | To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 1 FOR, 1 ABSTAIN |
| CVB FINANCIAL CORP. | May 20, 2026 | To approve, on a non-binding advisory basis, the compensation of CVB Financial Corp.'s named executive officers ("Say-on-Pay"). Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| CVB FINANCIAL CORP. | May 20, 2026 | To ratify the appointment of KPMG LLP as independent registered public accountants of CVB Financial Corp. for the year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| CVR ENERGY, INC. | June 4, 2026 | To ratify the appointment of Grant Thornton LLP as CVR Energy, Inc.'s independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| CVS HEALTH CORPORATION | May 14, 2026 | Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026. Audit-related |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| CVS HEALTH CORPORATION | May 14, 2026 | Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. Say-on-Pay |
Board | For | FOR 13 funds |
Split 8 FOR, 2 ABSTAIN |
| CYTOKINETICS, INCORPORATED | May 27, 2026 | To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance thereunder by 1,000,000 shares of common stock. Compensation |
Board | For | FOR 8 funds |
Split 8 FOR, 2 AGAINST |
| CYTOKINETICS, INCORPORATED | May 27, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| CYTOKINETICS, INCORPORATED | May 27, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 8 FOR, 2 ABSTAIN |
| Contemporary Amperex Technology Co., Ltd. | December 25, 2025 | Approve Additional Cap for Provision of Guarantee Capital Structure |
Board | For | AGAINST 8 funds |
Split 1 FOR, 2 AGAINST |
| Contemporary Amperex Technology Co., Ltd. | December 25, 2025 | Approve Grant of a General Mandate to the Board to Issue Shares Capital Structure |
Board | For | AGAINST 8 funds |
Split 1 FOR, 2 AGAINST |
| Costamare Inc. | October 2, 2025 | Elect Director Charlotte Stratos Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 3 AGAINST |
| Costamare Inc. | October 2, 2025 | Elect Director Konstantinos Konstantakopoulos Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 3 AGAINST |
| D'IETEREN GROUP | May 28, 2026 | Reelect Diligencia Consult SRL, Represented by Diane Govaerts, as Independent Director Director Elections |
Board | For | FOR 4 funds |
Split 2 FOR, 1 AGAINST |
| D-WAVE QUANTUM INC. | June 4, 2026 | To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| DANA INCORPORATED | April 22, 2026 | Approval of a non-binding advisory proposal approving executive compensation. Say-on-Pay |
Board | For | FOR 5 funds |
Split 5 FOR, 1 ABSTAIN |
| DANAHER CORPORATION | May 5, 2026 | To approve on an advisory basis the Company's named executive officer compensation. Say-on-Pay |
Board | For | Split 1 FOR, 20 AGAINST |
Split 9 FOR, 2 ABSTAIN |
| DANAHER CORPORATION | May 5, 2026 | To approve the Company's Amended and Restated Omnibus Incentive Plan. Compensation |
Board | For | FOR 17 funds |
Split 9 FOR, 2 ABSTAIN |
| DANAHER CORPORATION | May 5, 2026 | To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 17 funds |
Split 8 FOR, 1 AGAINST, 2 ABSTAIN |
| DANONE SA | April 23, 2026 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans Compensation |
Board | For | FOR 6 funds |
Split 3 FOR, 1 AGAINST |
| DANONE SA | April 23, 2026 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees of International Subsidiaries Compensation |
Board | For | FOR 6 funds |
Split 3 FOR, 1 AGAINST |
| DARLING INGREDIENTS INC. | May 7, 2026 | Approve, on an advisory basis, executive compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
Split 3 FOR, 1 ABSTAIN |
| DARLING INGREDIENTS INC. | May 7, 2026 | Ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending January 2, 2027. Audit-related |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| DASSAULT SYSTEMES SE | May 20, 2026 | Approve Compensation Report of Corporate Officers Compensation |
Board | For | AGAINST 3 funds |
Split 1 FOR, 2 AGAINST |
| DASSAULT SYSTEMES SE | May 20, 2026 | Approve Remuneration Policy of Corporate Officers Compensation |
Board | For | AGAINST 3 funds |
Split 1 FOR, 2 AGAINST |
| DASSAULT SYSTEMES SE | May 20, 2026 | Authorize up to 1.5 Percent of Issued Capital for Use in Restricted Stock Plans Compensation |
Board | For | FOR 3 funds |
Split 1 FOR, 2 AGAINST |
| DASSAULT SYSTEMES SE | May 20, 2026 | Elect Eric Trappier as Director Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 2 AGAINST |
| DASSAULT SYSTEMES SE | May 20, 2026 | Reelect Pascal Daloz as Director Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 2 AGAINST |
| DATADOG, INC. | April 21, 2026 | To approve the redomiciliation of the Company from the State of Delaware to the State of Nevada by conversion. Extraordinary Transactions |
Board | For | AGAINST 9 funds |
Split 1 FOR, 8 AGAINST, 4 ABSTAIN |
| DATADOG, INC. | June 15, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 11 funds |
Split 9 FOR, 3 ABSTAIN |
| DATADOG, INC. | June 15, 2026 | To ratify the selection by the Audit Committee of our Board of Directors of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 9 funds |
Split 9 FOR, 3 ABSTAIN |
| DAUCH CORPORATION | April 30, 2026 | Approval of Amended and Restated 2018 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
Split 3 FOR, 1 ABSTAIN |
| DAUCH CORPORATION | April 30, 2026 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
Split 3 FOR, 1 ABSTAIN |
| DAUCH CORPORATION | April 30, 2026 | Ratification of the appointment of Deloitte and Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 1 fund |
Split 3 FOR, 1 ABSTAIN |
| DAVE INC. | June 2, 2026 | Advisory approval of Dave's executive compensation. Say-on-Pay |
Board | For | ABSTAIN 1 fund |
Split 1 FOR, 1 ABSTAIN |
| DAVE INC. | June 2, 2026 | Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of Dave Inc. for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 1 fund |
Split 1 FOR, 1 ABSTAIN |
| DAVITA INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 2 ABSTAIN |
| DELEK US HOLDINGS, INC. | April 20, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| DELEK US HOLDINGS, INC. | April 20, 2026 | To adopt the advisory resolution approving the executive compensation program for our named executive officers as described in the Proxy Statement. Say-on-Pay |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| DELL TECHNOLOGIES INC. | June 25, 2026 | Approval of the Redomestication Proposal providing for the redomestication of Dell Technologies Inc. from Delaware to Texas by conversion as disclosed in the proxy statement Extraordinary Transactions |
Board | For | FOR 4 funds |
Split 3 AGAINST, 4 ABSTAIN |
| DELL TECHNOLOGIES INC. | June 25, 2026 | Approval, on a non-binding, advisory basis, of the compensation of Dell Technologies Inc.'s named executive officers as disclosed in the proxy statement Say-on-Pay |
Board | For | FOR 7 funds |
Split 3 AGAINST, 4 ABSTAIN |
| DELL TECHNOLOGIES INC. | June 25, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as Dell Technologies Inc.'s independent registered public accounting firm for the fiscal year ending January 29, 2027 Audit-related |
Board | For | FOR 4 funds |
Split 2 FOR, 1 AGAINST, 4 ABSTAIN |
| DELTA AIR LINES, INC. | June 18, 2026 | To approve, on an advisory basis, the compensation of Delta's named executive officers. Say-on-Pay |
Board | Not determined | FOR 20 funds |
Split 4 FOR, 2 ABSTAIN |
| DELTA AIR LINES, INC. | June 18, 2026 | To ratify the appointment of Ernst & Young LLP as Delta's independent auditors for the year ending December 31, 2026. Audit-related |
Board | Not determined | FOR 16 funds |
Split 4 FOR, 2 ABSTAIN |
| DEMANT A/S | March 5, 2026 | Reelect Niels Jacobsen as Director Director Elections |
Board | Not determined | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| DENALI THERAPEUTICS INC. | June 3, 2026 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 4 funds |
Split 4 FOR, 2 ABSTAIN |
| DENALI THERAPEUTICS INC. | June 3, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 2 ABSTAIN |
| DENTSPLY SIRONA INC. | June 2, 2026 | Approval of Amendment No. 2 to the 2024 Omnibus Incentive Plan to increase the number of shares of the Company's Common Stock issuable under such Plan. Compensation |
Board | For | AGAINST 1 fund |
Split 2 FOR, 1 ABSTAIN |
| DENTSPLY SIRONA INC. | June 2, 2026 | Approval, by non-binding vote, of the Company's executive compensation for 2025. Say-on-Pay |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
← Previous Page 9 of 36 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.